ClinicalTrials HQ

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Recruiting · NCT06451770 · Registry updated 2026-07-17
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 1b Study of VERVE-201 in Patients With Refractory HyperlipidemiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, inborn errors of metabolism, metabolic diseaseRecruitingPhase 12026-07-17NCT06451770

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Verve Therapeutics, Inc.4

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Clinical Study CenterJohannesburgSouth Africa1
Clinical Study CenterMelbourneAustralia3
Clinical Study CenterManchesterUnited Kingdom2
Clinical Study CenterTorontoCanada2
Clinical Study CenterChicoutimiCanada2
Clinical Study CenterLondonUnited Kingdom6
Clinical Study CenterMiami LakesUnited States1
Clinical Study CenterAdelaideAustralia3
Clinical Study CenterClearwaterUnited States1
Clinical Study CenterLiverpoolUnited Kingdom1
Clinical Study CenterAmsterdamNetherlands1
Clinical Study CenterCape TownSouth Africa1
Clinical Study CenterPort OrangeUnited States1
Clinical Study CenterMontrealCanada2
Clinical Study CenterNew YorkUnited States1
Clinical Study Center 2ManchesterUnited Kingdom1